These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3908528)

  • 1. Topical application of 3-carbethoxypsoralen plus UVA in the treatment of psoriasis.
    Kimura S; Mizuno N; Hirano S; Yoshikawa K
    J Dermatol; 1985 Jun; 12(3):251-7. PubMed ID: 3908528
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA.
    Takashima A; Yamamoto K; Kimura S; Takakuwa Y; Mizuno N
    Br J Dermatol; 1991 Jan; 124(1):37-42. PubMed ID: 1993143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic actinic dermatitis developed during phototherapy for psoriasis.
    Fujii N; Uetsu N; Hamakawa M; Futamura S; Okamoto H; Horio T
    Photodermatol Photoimmunol Photomed; 2002 Jun; 18(3):157-9. PubMed ID: 12207682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice.
    Dubertret L; Averbeck D; Zajdela F; Bisagni E; Moustacchi E; Touraine R; Latarjet R
    Br J Dermatol; 1979 Oct; 101(4):379-89. PubMed ID: 389271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Methylangelicins: new monofunctional photochemotherapeutic agents for psoriasis.
    Cristofolini M; Recchia G; Boi S; Piscioli F; Bordin F; Baccichetti F; Carlassare F; Tamaro M; Pani B; Baburdi N
    Br J Dermatol; 1990 Apr; 122(4):513-24. PubMed ID: 2337519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
    Gasparro FP
    Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and therapeutic effectiveness of selected psoralens in psoriasis.
    Wolff K; Hönigsmann H
    Natl Cancer Inst Monogr; 1984 Dec; 66():159-64. PubMed ID: 6531023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
    Väätäinen N; Hollmen A; Fräki JE
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralens and related compounds in the treatment of psoriasis.
    McEvoy MT; Stern RS
    Pharmacol Ther; 1987; 34(1):75-97. PubMed ID: 3310045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen photochemistry.
    Parsons BJ
    Photochem Photobiol; 1980 Dec; 32(6):813-21. PubMed ID: 7005917
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems posed by the therapeutic use of photosensitizers in dermatology].
    Beani JC; Amblard P; Reymond JL
    Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bullous pemphigoid induced by photochemotherapy of psoriasis. Apropos of 2 cases, with a review of the literature].
    Brun P; Baran R
    Ann Dermatol Venereol; 1982; 109(5):461-8. PubMed ID: 6753695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?
    Lindelöf B
    Drug Saf; 1999 Apr; 20(4):289-97. PubMed ID: 10230579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group.
    Halpern SM; Anstey AV; Dawe RS; Diffey BL; Farr PM; Ferguson J; Hawk JL; Ibbotson S; McGregor JM; Murphy GM; Thomas SE; Rhodes LE
    Br J Dermatol; 2000 Jan; 142(1):22-31. PubMed ID: 10651690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity of trioxsalen bath PUVA.
    Hannuksela M; Karvonen J
    J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):813-4. PubMed ID: 2808807
    [No Abstract]   [Full Text] [Related]  

  • 16. PUVA improvements will come from molecular biology.
    Gasparro FP
    Photodermatol Photoimmunol Photomed; 2000 Apr; 16(2):83-4. PubMed ID: 10823319
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical efficacy of psoralen + sunlight vs. combination of isotretinoin and psoralen + sunlight for the treatment of chronic plaque-type psoriasis vulgaris: a randomized hospital-based study.
    Gahalaut P; Soodan PS; Mishra N; Rastogi MK; Soodan HS; Chauhan S
    Photodermatol Photoimmunol Photomed; 2014 Dec; 30(6):294-301. PubMed ID: 24828298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis.
    Grundmann-Kollmann M; Ludwig R; Zollner TM; Ochsendorf F; Thaci D; Boehncke WH; Krutmann J; Kaufmann R; Podda M
    J Am Acad Dermatol; 2004 May; 50(5):734-9. PubMed ID: 15097957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact and photocontact allergy to psoralens.
    Möller H
    Photodermatol Photoimmunol Photomed; 1990 Feb; 7(1):43-4. PubMed ID: 2371173
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacokinetics of methoxsalen and other psoralens.
    de Wolff FA; Thomas TV
    Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.